IVD News and Research

RSS
Breakthrough injectable gel for treating degeneration of the intervertebral disc

Breakthrough injectable gel for treating degeneration of the intervertebral disc

FDA clears Meridian's new C. difficile immunoassay

FDA clears Meridian's new C. difficile immunoassay

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

MicroPhage receives FDA clearance for KeyPath MRSA/MSSA Blood Culture Test

MicroPhage receives FDA clearance for KeyPath MRSA/MSSA Blood Culture Test

BD MAX Open System for molecular testing launched in Europe

BD MAX Open System for molecular testing launched in Europe

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

ChipDX identifies gene expression signature in early-stage breast tumors

ChipDX identifies gene expression signature in early-stage breast tumors

FDA grants Cepheid marketing clearance for Xpert Flu diagnostic test

FDA grants Cepheid marketing clearance for Xpert Flu diagnostic test

EraGen, Applied BioCode partner to commercialize molecular diagnostics

EraGen, Applied BioCode partner to commercialize molecular diagnostics

New dengue test receives FDA marketing clearance

New dengue test receives FDA marketing clearance

Cepheid receives FDA clearance for new assay to detect C. difficile infection

Cepheid receives FDA clearance for new assay to detect C. difficile infection

Bruker receives Health Canada approval for IVD MALDI Biotyper

Bruker receives Health Canada approval for IVD MALDI Biotyper

Luminex receives Medical Design Excellence Award for innovative MAGPIX system

Luminex receives Medical Design Excellence Award for innovative MAGPIX system

EDMA endorses the campaign against excessive use of salt

EDMA endorses the campaign against excessive use of salt

Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share

Quest Diagnostics enters definitive merger agreement to acquire Celera for $8 per share

ExonHit receives CE mark approval for AclarusDx to diagnose AD

ExonHit receives CE mark approval for AclarusDx to diagnose AD

Fluidigm fourth quarter revenue increases to $10.4 million

Fluidigm fourth quarter revenue increases to $10.4 million

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays